Browse by Author Hui, CK

TitleAuthor(s)YearView Count
The effect of modal energy transfer on the sound radiation and vibration of a curved panel: Theory and experimentLee, YY; Su, RKL; Ng, CF; Hui, CK2009230
Prevalence and time trend of intestinal metaplasia in Hong KongYee, YK; Wong, KW; Hui, CK; Chan, CK; Chan, AOO; Lam, SK; Fung, FMY; Hung, I; Wong, BCY2009154
Corrigendum to "96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B". J Hepatol 48 (2008) 714-720 (DOI:10.1016/j.jhep.2007.10.013)Hui, CK; Zhang, HY; Bowden, S; Locarnini, S; Luk, JM; Leung, KW; Yueng, YH; Wong, A; Rousseau, F; Yuen, KY; Naoumov, NN; Lau, GKK200952
Human metapneumovirus infection in an immunocompetent adult presenting as mononucleosis-like illnessLi, IWS; To, KKW; Tang, BSF; Chan, KH; Hui, CK; Cheng, VCC; Yuen, KY2008120
Silver nanoparticles inhibit hepatitis B virus replicationLu, L; Sun, RWY; Chen, R; Hui, CK; Ho, CM; Luk, JM; Lau, GKK; Che, CM2008613
Outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimenHui, CK; Cheung, WW; Leung, KW; Cheng, VCC; Tang, SF; Li, WS; Lee, NP; Kwong, YL; Au, WY; Yuen, KY; Lau, G; Liang, RHS2008125
Changes in liver histology as a surrogate endpoint of antiviral therapy for chronic HBV can predict progression to liver complicationsHui, CK; Leung, N; Shek, TWH; Zhang, H; Luk, JMC; Poon, RTP; Lo, CM; Fan, ST; Lau, G2008109
Retracted: outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimen.Hui, CK; Cheung, WW; Leung, KW; Cheng, VC; Tang, BS; Li, IW; Luk, JM; Lee, NP; Kwong, YL; Au, WY; Yuen, KY; Lau, GK; Liang, R200855
Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complicationsHui, CK; Leung, N; Shek, WH; Zhang, HY; Luk, JM; Poon, RTP; Lo, CM; Fan, ST; Lau, GKK200858
96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis BHui, CK; Zhang, HY; Bowden, S; Locarnini, S; Luk, JM; Leung, KW; Yueng, YH; Wong, A; Rousseau, F; Yuen, KY; Naoumov, NN; Lau, GKK200878
Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis BHui, CK; Zhang, HY; Lee, NP; Chan, W; Yueng, YH; Leung, KW; Lu, L; Leung, N; Lo, CM; Fan, ST; Luk, JM; Xu, A; Lam, KS; Kwong, YL; Lau, GKK2007128
Oral arsenic trioxide therapy for acute promyelocytic leukemia before and after liver transplantation for hepatitis B virus-related liver failure [3]Au, WY; Liu, CL; Tam, S; Fong, BMW; Shek, TW; Hui, CK; Kwong, YL200739
Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathminChen, Y; Lin, MC; Yao, H; Wang, H; Zhang, AQ; Yu, J; Hui, CK; Lau, GK; He, ML; Sung, J; Kung, HF200747
Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat modelLuk, JM; Zhang, QS; Lee, NP; Wo, JY; Leung, PP; Liu, LX; Hu, MY; Cheung, KF; Hui, CK; Lau, GK; Fan, ST200784
Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patientsHui, CK; Leung, N; Shek, TWH; Yao, H; Lee, WK; Lai, JY; Lai, ST; Wong, WM; Lai, LSW; Poon, RTP; Lo, CM; Fan, ST; Lau, GKK2007177
The use of transient elastography as a preoperative assessment of hepatic resection (Abstract)Lai, L; Hui, CK; Poon, RTP; Shek, TWH; Lai, ST; Lai, JY; Lo, CM; Fan, ST; Leung, N; Lau, G2007118
Traditional Chinese herbalmedicines for treatmentof liver¢brosis and cancer: fromlaboratorydiscovery to clinical evaluationLuk, JM; Wang, XL; Liu, P; Wong, KF; Chan, KL; Tong, Y; Hui, CK; Lau, GK; Sheung, TF200797
Lentivirus-mediated RNA Interference Targeting Enhancer of Zeste Homolog 2 Inhibits Hepatocellular Carcinoma Growth Through Down-regulation of Stathmin (Erratum in: Hepatology. 2007 Oct;46(4):1314)Chen, Y; Lin, MC; Yao, H; Wang, H; Zhang, AQ; Yu, J; Hui, CK; Lau, G; He, ML; Sung, J; Kung, HF2007202
In Vitro Anti-hepatitis B Virus Activities and Mechanism of Silver Nanoparticles,The 17th Asian Pacific Association for the Study of the Liver Conference, Kyoto, Japan, 27 - 30 March 2007Lu, L; Sun, RWY; Hui, CK; Chen, R; Luk, JMC; Che, CM; Lau, G2007103
Size-dependent anti-hepatitis B virus activities and mechanism of silver nanoparticles (Abstract)Lu, L; Sun, RWY; Hui, CK; Chen, R; Luk, JMC; Che, CM; Lau, G2007135